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Pharmacotherapy
The relative lack of information on the disposition or
efficacy of cardiovascularand other drugs, as well as drug
interactions, has been a major impediment in the drug treat-
ment of elderly patients. This is because drugs have gen-
erally beenstudiedin healthy, young, normal, usuallymale,
volunteers . A series of conferences addressing this problem
has resulted in the inclusion of elderly patients in current
trials of drug disposition, dose ranging and drug efficacy.
However, inadequate information is available for a large
number of already marketeddrugs used in the elderly. Car-
diovascular drugs, particularly those with narrow therapeu-
tic ratios. should be studied in well designed clinical trials
in appropriate older subjects so that proper guidelines for
their usecan be provided. In this categoryare antiarrhythmic
agents, anticoagulant drugs, inotropic agents and the more
potent antihypertensive drugs. Even when this information
becomes available. the physician is still obligated to indi-
vidualize drug treatment in the elderly, given the recognized
variability of their response to drugs.
An individual's response to a drug may be determined
either by the way the drug is distributed in or excreted by
the body (drug pharmacokinetic changes) or by the indi-
vidual's sensitivity to thedrug (pharmacodynamic changes).
Pharmacokinetic Changes With Aging
Alterations with aging have been found in the ability to
metabolize drugs, in drug distribution and in the renal ex-
cretion of drugs, all of which may influence plasma drug
concentrations (1-5) .
Renal excretion. For drugs principaJly excreted by the
kidney. a reduction in.glomerular filtration rate may de-
crease the clearanceof the drug. Recent studies suggest that
there is not an inevitable decrease in creatinine clearance
with advancing age in healthy subjects. However, the clear-
ance of renally excreted drugs is significantly reduced in
theelderly. A well knownexampleof such a drug isdigoxin,
whoserenalclearance is lower in theelderly. This decreased
clearance is associated with a reduced glomerular filtration
rate and increased plasma digoxin concentrations, with an
increased risk of toxicity.
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Hepatic metabolism, Hepatic drug metabolism may also
be altered in the elderly, resultingin elevation in the plasma
concentration of drugs whose principal route of metabolism
is by the liver. For example, aging significantly reduces the
hepatic clearance of propranolol, such that blood propran-
olol concentrations are twofold higher in older patients than
in the young (5). Changes in drug metabolizing ability with
aging are complex. Smokers metabolize many drugs more
rapidly than do nonsmokers. The ability of cigarette smok-
ing to induce hepatic drug metabolism appears to decrease
with advancingage, so that smoking increases the clearance
of highly metabolized drugs predominantly in the young. It
appears that aging predominantly affects the oxidative me-
tabolism of drugs, while those drugs whose principal route
of metabolism is by synthetic pathways, such as conjuga-
tion, are relatively unaffected by aging (6).
Drug clearance. Changes in drug clearance, whether
due to altereddrug metabolism or to altered renal excretion,
imply that drug dosage in elderly patients has to be chosen
with great care, and that drug dosage has to be lower for
those drugs whose clearance is reduced with aging.
Pharmacodynamic Changes With Aging
Altered responses to similar drug concentrations may
occur either because of alterations in the sensitivity of the
target organ to drug effect or because of alterations in the
responsiveness of the compensatory reflexes that normally
limit the hemodynamic effects of a drug. Both these alter-
ations occur in the elderly. The beta-adrenergic receptor
system is the best studied system in aging humans. The
sensitivity of beta-adrenergic receptors in cardiac and vas-
cular tissues to stimulation by beta-adrenergic agonists de-
creases with advancing age. Studies in humans have shown
that the elderly are less sensitive to the chronotropic effects
of isoproterenol. requiringa largerdose to producethe same
increase in pulse rate achieved in younger persons (7). Also,
the elderly require higher concentrations of propranolol to
produce the same degree of beta-blockade (7) . Both in iso-
lated vascular tissues and in vivo, vascular relaxation and
response to beta-receptor agonists are decreased with ad-
vancing age (g). These changes produce alterations in re-
sponse to drugs that interact directly with the affected re-
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ceptors; they also have indirect effects in decreasing the
sensitivity of beta-receptor response because they impair
compensatory reflexes. For example. when elderly patients
receive vasodilator or antihypertensive agents. the reflex
sympathetic stimulation, which such hypotension normally
evokes. causes a diminished heart rate response.
Effe cts of Concomitant Diseases on Drug Therapy in
rhe Elderly
There is an increased likelihood with advancing age that
patients have recognized or unrecognized concomitant dis-
eases that may adversely affect their response to cardio-
vascular drugs. For example. it is important to consider that
an elderly patient may have overt or silent coronary artery
disease before prescribing a potent vasodilator such as min-
oxidil or hydralazine. The increased myocardial oxygen
demand caused by minoxidil- or hydralazine-induced vaso-
dilation and reflex tachycardia may precipitate angina pec-
toris or myocardial infarction. Any drug likely to produce
a large postural decrease in blood pressure is inappropriate
for elderly patients because of their diminished compen-
salary reflex responses.
The risks of centrally acting antihypertensive drugs are
unclear. It has been suggested that the elderly are more
sensitive to the central nervous system depressant effects of
drugs such as methyldopa; however. in a recent study of
the treatment of hypertension in the elderly (EWPHE Study),
methyldopa was well tolerated (9) .
Drug Interactions
Because of the frequency with which elderly patients
receive multiple medications, often from multiple sources,
they are particularly likely to be subject to drug interac-
tions. These interactions include interference by one drug
with the absorption, distribution or excretion of another
(pharmacokinetic interaction) as well as drug interaction at
the receptor level. Perhaps the most common form of drug
interaction occurs when two concomitantly administereddrugs
have a similar effect, and thus produce additive pharma-
cologic actions. These actions are frequently not the primary
pharmacologic effect of the drugs but are a secondary or
unwanted effect, not anticipated by the physician. For ex-
ample, if two drugs with mild sedative action are given
together. the combined sedative effect may be severe. Un-
fortunately, drug side effects are often unrecognized in el-
derly patients because the patient' s signs or symptoms are
ascribed either to the underlying disease or to " old age."
Cardiac effects of noncardiac medications. The el-
derly are frequent users of analgesics, antacids, laxatives,
antidepressants, sedatives, bronchodilators and ophthalmic
beta-receptor blockers. Some of these agents are prescrip-
tion drugs, but manyothers may be obtained over the counter.
Many of these agents have cardiac effects that may be de-
leterious to patients with occult or overt cardiac disorders.
For example, the high sodium content of antacids may cause
volume expansion and precipitate heart failure. Sympatho-
mimetic bronchodilators increase heart rate and may be ar-
rhythmogcnic: they may be especially deleterious in patients
with coronary artery disease. unmasking or worsening an-
gina pectoris and ventricular arrhythmias. Antidepressant
agents can precipitate arrhythmias.
The nonsteroid anti-inflammatory drugs are commonly
used by elderly patients both as prescription and as non-
prescriptionagents, These drugs interfere with prostaglandin
synthesis and raise blood pressure by several mechanisms,
including sodium retention. The effects may vary from drug
to drug and from patient to patient.
Simplification of drug regimens should be the goal for
both elderly and young patients. However, at least in a trial
of antihypertensive therapy. the elderly appeared to show
as good compliance as did the young (10, ll).
Recommendations
Drug therapy for elderly patients is based on principles
similar to those used to choose therapy in the young. How-
ever, because of the greater risk of adverse drug reactions
in the elderly. there should be more attention to possible
unwanted drug effects. Specifically. greater care is needed
in adjusting drug dosage in elderly patients because of their
impaired ability to excrete some drugs. In addition, impaired
homeostatic mechanisms may accentuate the response to
normal concentrations of drugs. Because of all these changes.
therapy in elderly patients should be started at lower doses
than is usual in younger patients, and the dose should be
advanced slowly if necessary. Drug response should be care-
fully monitored. Because elderly patients often receive mul-
tiple drugs, the physician should be alert to drug interactions
and should also avoid the coadministration of drugs with
similar effects. These effects may be subtle; for example,
the coadministration of a benzodiazopine tranquilizer and a
centrally acting antihypertensive drug such as methyldopa.
may both produce sedation.
Finally, the elderly may not recognize and frequently do
not spontaneously complain of drug side effects; potential
unwanted effects must be assessed by direct questioning.
Diet and Exercise
Nutrition and physical activity both play important roles
in maintaining normal cardiovascular function in the elderly
and arc the major nonpharmacologic approaches to the treat-
ment of hypertension and the prevention of coronary heart
disease in individuals of all ages. Physical activity that is
well maintained in elderly individuals is associated with





lower blood pressure and more favorable metabolic char-
acteristics than are observed in sedentary individuals (12).
Thus, diet and exercise appear to have a profound influence
on health and disease. Our concern is to determine the
benefits and hazards of diet and exercise in the elderly.
Nutriti on in the Elderly
There is a lack of consensus concerning recommended
dietary allowances that might contribute to the health of the
elderly, in part because individuals age at different rates.
and various physiologic functions deteriorate in unpredict-
able ways. so that there is great heterogeneity of physiologic
function and. presumably, of nutritional requirements in the
elderly ( 13) . Furthermore, there are inevitableconsequences
of disease and medical treatment on intake and absorption
of essential nutrients. Nutritional requirements must also
take into account that lean body mass declines continually
throughout life, with an average loss of about 6.3% for each
decade (14), and an increase of adipose tissue with age.
Carbohydrate and fat metabolism . Aging has an effect
on carbohydrate and fat metabolism and inevitably involves
a decrease in glucose utilization after glucose loading (15).
This appears to be associated with insulin antagonism: a
rise in the level of plasma insulin has been observed. As a
result, the glucose that is not metabolized through the gly-
colytic cycle is used for synthesis of triglycerides. Free fatty
acids become the main source of energy supply. High cir-
culating plasma levels of free fatty acids enhance the syn-
thesis of triglycerides and very low density lipoproteins.
High levels of free fatty acids may promote clinical com-
plications of ischemic heart disease in elderly individuals.
Dietary intervention for hyperlipidemia. With age.
there is a rising incidence and prevalence of cardiovascular
disease, As in young adults, elderly individuals with high
levels of atherogenic lipids develop more cardiovascular
disease (16). The success of several trials in reducing mor-
bidity and mortality from coronary heart disease (17,18) has
focused attention on lowering blood lipids as a preventive
strategy, Deaths from myocardial infarction and progression
of coronary lesions also were reduced when blood lipid
levels were reduced by administration of cholestyramine or
marked reduction in intake of saturated fat. The greatest
benefits were observed in patients with a high ratio of total
to high density lipoprotein cholesterol (18). Patients with
these characteristics are the ones most likely to benefit from
dietary intervention,
Hypertension and nutritional risk factors. Hyperten-
sion, particularly isolatedsystolic hypertension, is common
in elderly individuals. Although risk factors for the devel-
opment of hypertension have not been well defined, a num-
ber of possibilities include obesity and dietary intake of
sodium, potassium, calcium, fat and alcohol. All these risk
factors may be classified as nutritional,
Weight reduction. Weight reduction can reduce blood
pressure independently of dietary sodium restriction (19,20),
Small amounts of weight loss usually will lower blood pres-
sure even in individuals who are not obese (21). Sodium
restriction has been effective in lowering blood pressure in
some individuals (22). Elderly individuals, particularly those
withsevere hypertension and low renin values, may respond
to sodium restriction. Decreased fat intake or increased in-
take of polyunsaturated fatty acids also has been reported
to reduce blood pressure (23), These data suggest that it is
reasonable to moderately restrict sodium intake in the elderly
to 75 to 100 mmollday. Dietary calcium intake should be
maintained to prevent osteoporosis. Reduction of fat intake
might have its greatest efficacy by lowering caloric intake
and reducing obesity.
Physical Activity in the Elderly
The effects of physical conditioning in the elderly have
been compared in studies of individuals who are sedentary
and those who are physically active (24). A progressive
decline in maximal oxygen uptake is observed with age, but
sedentary individuals have a 10to 20% decrement compared
with active individuals of the same age (25,26), Elderly
individuals who are physically active may have a greater
endurance capacity than younger sedentary individuals, Other
health characteristics are also well maintained in physically
active elderly individuals.
Endurance training. Endurance training also can im-
prove the physical working capacity of sedentary elderly
individuals (Table I). Maximal oxygen uptake increases
(27,28) as evidence of endurance conditioning. Vigorous
exercise in elderly individuals also appears associated with
a reduced incidence of myocardial infarction. Paffenbarger
et al. (29) reported the results of a physical activity survey
of 16.936 Harvard male alumni aged 35 to 74 years, of
whom 572 experienced heart attacks in 117,680 person-
years of follow-up. Menwith a physical activity index < 2.000
kcal/week were at 65% higher risk than were classmates
with a higher index. Although individuals aged 65 to 74
years had a higher rate of heart anack than those in younger
age groups. individuals with a physical activity index > 2.000
kcal/week had less than half the rate of heart attack expe-
rienced by those with a physical activity index less than 500
kcallweek. Physically active elderly individuals had lower
rates of heart attack than those who were sedentary.
Regular exercise. Exercise training elicits beneficial
physiologic and metabolic responses in skeletal muscle and
the cardiopulmonary system, Prescription of regular exer-
cise for elderly patients should consider the individual' s
maximal oxygen uptake. corrected for age, sex and lean
body mass. Regular isotonic exercise. particularly walking,




Table 1. Results of Symptom-Limited Maximal Spiroergometry Before and After Systematic
Bicycle Ergometer Training of 12 Weeks Duration*
No. of Before After
Patients Training Training p Value
Max HR (min~l) 12 147 ± I3t 147 ± 16 NS
Max work load (W) 12 III ± 36 129 ± 29 <0.01
V02 max (ml min-I) 8 1,623 ± 423 1,856 ± 480 <0.01
ABEmax 10 4.5 ± 1.I 5.6 ± 1.4 NS
Submax HR 12 135 ± 12 125 ± 14 <0.5
(min-I)
V E- max (I min-I) 8 52 ± 18 60 ± 21 NS
*Eight womenand four men aged 67 to 76 years(mean71.1). tMean ± SD. ABEmax = maximaldifference
between base excess at rest and during exhausting exercise; Max HR = maximal heart rate; Submax HR =
heart rate at the same submaximal exercise level; VE~max = maximalventilation; V02 max = maximal oxygen
uptake. (Adapted from Haber P, et al. [28]).
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Exercise Testing in the Elderly
Exercise testing is safe and effective for the evaluation
of cardiovascular status in elderly patients. The degree of
ST depression during exercise testing is a reliable predictor
of the extent of coronary artery disease (30). The extent of
rise in systolic blood pressure during an exercise test is
reported to be the single best predictor of subsequent mor-
bidity and mortality (31). A low increase of the pressure-
rate product from rest to maximal exercise and OCCurrence
of significant exercise-associated ventricular arrhythmias may
identify a high risk group Ofpatients with substantially re-
duced probability for survival compared with patients with-
out these responses.
Elderly individuals respond to submaximal and maximal
exercise tests similarly to younger individuals (30,32,33).
However, maximal heart rate is significantly lower in pa-
tients >65 years of age. Systolic blood pressure is higher
in older patients at rest and during exercise, but diastolic
blood pressure is the same in both age groups. At the same
intensity of exercise, heart rate tends to be lower and blood
pressure higher in older than in younger individuals.
Pharmacologic testing. It may be difficult for some
elderly persons to perform a maximal exercise test because
of physical limitations associated with orthopedic, neuro-
logic or musculoskeletal conditions. Under these circum-
stances, diagnostic information can be obtained with phar-
macologic testing, such as intravenous or oral dipyridamole
administration during thallium imaging, to maximize coro-
nary flow heterogeneity (34).
Arm exercise testing. Another alternative to treadmill
or bicycle ergometer exercise testing is an arm exercise test.
Arm ergometry using a hand-cranked bicycle ergometer can
help evaluate individuals with heart disease. In assessing
the severity of coronary heart disease, arm ergometry can
be combined with thallium scintigraphy (35).
Psychologic Benefits of Exercise
Studies of the psychologic effects of aerobic exercise
training (36) have shown that aerobic exercise can improve
mood (37), reduce psychophysiologic responsivity to be-
havioral stressors (38,39) and improve self-esteem (40,41)
in both the young and the old. In addition, aerobic exercise
may improve cognitive functioning and psychomotor speed
(42).
Dustman et al. (43) showed that older adults (55 to 70
years of age) achieved a 27% increase in maximal oxygen
consumption after a 4 month aerobic exercise program. This
was accompanied by improvement both in simple reaction
time performance and in a measure of resistance to percep-
tual distraction (Stroop task). Thus, exercise may improve
psychologic and cognitive functioning in the elderly.
Adherence to Prescribed Exercise
Attitudes about exercise and health may influence ad-
herence to cardiac rehabilitation exercise. Sidney and Shep-
hard (44), studying the activity patterns of men and women
2:60 years of age found that elderly individuals seldom
engage in heavy physical activity. Heart rates during con-
tinuous electrocardiographic recording indicated that elderly
subjects overestimated the time spent on heavy physical
activity, as compared with ratings by younger adults in
similar studies. Attitudes toward physical activity may in-
fluence the compliance of elderly patients with exercise
rehabilitation after myocardial infarction. Gori et al. (45)
reported that only 12% of patients >65 years completed a
4 month program.
Factors contributing to noncompliance. An important
step in overcoming noncompliance involves identification
of factors in both the individual and the environment that
contribute to noncompliance. Compliance refers to the de-





gree to which a person's behavior in taking medications.
following a diet,exercising or executing otherlifestyle changes
coincideswith medicalor healthadvice (46). Characteristics
of a rehabilitation program, available social supports and
perceptions of the treatment regimen have to be assessed.
Although elderly cardiac patients are not at greater risk for
noncompliance, a number of factors associated with non-
compliance appear relevant for elderly cardiac patients. These
include an increased complexity and duration of treatment.
a high degree of behaviorchange required by the treatment,
the patients's limited perception of personal vulnerability
and the increased potential success of treatment contingent
on compliance (47). The patient's comprehension of the
treatment programappears to be the most important feature
favoring compliance.
Although few systematic efforts to increase compliance
with cardiac rehabilitation interventions have been pub-
lished, a variety of strategies for improvingcompliance are
appropriate for elderly cardiac patients; these include con-
venience. tailoringof theexerciseregimenforolderpersons.
delineationof goals specific for elderly patients and the like
(48).
Education of the Elderly Cardiac Patient
In planning health education programs for an elderly
population, medical! social and cultural barriers to com-
munication must be addressed for subsets of individuals .
Impaired vision and hearing exemplify physical handicaps,
and declining cognitive function and emotional instability
are examples of mental problems, Other subsetsof individ-
uals may be fragile or have concomitant diseases, or both.
The possible gains have to he weighed against risks of
changing lifelong habits, creating anxiety and engendering
negative reactions.
Educational messagesshould convey a recognition of the
patient's persunal worth. Suggestions for lifestyle interven-
tions should be madein moderation and at levelscompatible
with the patient's prior experience and age. Promotion of a
healthy lifestyle through smoking cessation. adequate diet.
reduced alcohol intake and regular physical activity can
provide important benefits to elderly patients who function
at a marginal level. Also important are stress reduction ,
development of social support networks and simplification
of daily life or work activities (49).
Summary
Recommendations concerning nutrition and physical ac-
tivity are an important part of health care in the elderly.
There is increasingevidence that diet and exercise influence
the development and progression of cardiovascular disease
in the elderly as well as the young. Decreases in coronary
risk factors can be achieved in the elderly by attention to
proper diet and exercise.
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